Role of ctDNA in Predicting the Outcome of Patients with Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer Treated with First-line Ribociclib and Letrozole: BioItaLEE Trial.
Saved in:
| Title: | Role of ctDNA in Predicting the Outcome of Patients with Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer Treated with First-line Ribociclib and Letrozole: BioItaLEE Trial. |
|---|---|
| Authors: | Bianchini G; Department of Medical Oncology, Ospedale San Raffaele, Milano, Italy., Malorni L; Translational Research Unit, Department of Oncology, Hospital of Prato, Azienda USL Toscana Centro, Prato, Italy., Caputo R; Department of Breast and Thoracic Oncology, IRCCS Istituto Nazionale dei Tumori Fondazione G Pascale, Napoli, Italy., Zambelli A; Medical Oncology Unit, Department of Biomedical Sciences, IRCCS Humanitas Research Hospital, Humanitas University, Milano, Italy., Puglisi F; Department of Medical Oncology, IRCCS, Centro di Riferimento Oncologico, Aviano, Italy.; Department of Medicine, University of Udine, Udine, Italy., Bianchi GV; SC Oncologia Medica 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Del Mastro L; Department of Internal Medicine and Medical Specialties, Università di Genova, Genoa, Italy.; Clinical Oncology Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Paris I; Gynecologic Oncology Unit, Department of Woman's and Child Health and Public Health Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Montemurro F; Istituto di Candiolo, FPO, IRCCS, Candiolo, Italy., Colleoni M; Senologia Medica, IEO Istituto Europeo di Oncologia, IRCCS, Milano, Italy., Allegrini G; U.O.C. Oncologia Medica, Presidio Ospedaliero Livorno, Livorno, Italy., Tamberi S; U.O. Oncologia, P.O. Ospedale degli Infermi - AUSL, Ravenna, Italy., Zamagni C; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Cazzaniga ME; Phase 1 Research Unit & Oncology Unit, Fondazione IRCCS San Gerardo dei Tintori, Milano Bicocca School of Medicine and Surgery, Monza, Italy., Orditura M; U.O.C. Oncologia Medica e Ematologia, A.O.U. Università degli Studi L. Vanvitelli, Napoli, Italy., Guarneri V; Deparment of Surgical, Oncological and Gastroenterological Sciences, Università di Padova, Padova, Italy.; Oncologia 2, Istituto Oncologico Veneto IOV, IRCCS, Padova, Italy., Adamo V; Scientific Consultant Oncology Project, Papardo Hopsital, Messina, Italy., Romagnoli E; U.O.C. Oncologia Presidio Ospedaliero di Macerata, ASUR Marche, Macerata, Italy., Valerio MR; U.O.C. di Oncologia Medica, Università degli Studi di Palermo, Palermo, Italy., Cinieri S; U.O.C. Oncologia Medica, Presidio Ospedaliero Antonio Perrino, Brindisi, Italy., Benelli M; Department of Oncology and Bioinformatics Unit, Ospedale di Prato, Azienda USL Toscana Centro, Prato, Italy., Callari M; Michelangelo Foundation, Milan, Italy., Valsecchi D; Oncology, Novartis Farma SpA, Milan, Italy., Castelletti D; Oncology, Novartis Farma SpA, Milan, Italy., Grasso D; Oncology, Novartis Farma SpA, Milan, Italy., Fenderico N; Oncology, Novartis Farma SpA, Milan, Italy., Arpino G; Department of Medical Clinics and Surgery, Università Federico II, Napoli, Italy., De Laurentiis M; Department of Breast and Thoracic Oncology, IRCCS Istituto Nazionale dei Tumori Fondazione G Pascale, Napoli, Italy. |
| Source: | Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2026 Jun 15; Vol. 32 (12), pp. 2428-2437. |
| Publication Type: | Journal Article; Clinical Trial, Phase III; Multicenter Study |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
